Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 33 citing D’Agostino: Cardiovascular disease risk factors predict the development of type 2 diabetes. (0.11 sec) 

Plasminogen activator inhibitor-1: a common denominator in obesity, diabetes and …


BD Taeye, LH Smith, DE Vaughan - Current Opinion in Pharmacology, 2005 - Elsevier
A classical perspective of cardiovascular risk does not adequately account for
all of the cardiovascular events associated with obesity and diabetes. The
combination of hypertriglyceridemia, glucose intolerance and inflammation ...
Cited by 62 - Related articles - All 2 versions

[PDF] Measures of adiposity and cardiovascular disease risk factors


A Menke, P Muntner, RP Wildman, K Reynolds … - Obesity, 2007 - 161.58.79.62
Introduction Higher adiposity has been shown in several previous studies to be
associated with an increased risk of cardiovas- cular disease and stroke
morbidity and mortality (1–3). BMI is a frequently used measure of ...
Cited by 17 - Related articles - View as HTML - All 6 versions

Diabetes and the metabolic syndrome—When is it best to intervene to prevent?


S Haffner - Atherosclerosis (Supplements)(Component), 2006 - Elsevier
In addition to microvascular complications, patients with type 2 diabetes are at
increased risk of cardiovascular disease (CVD) and mortality. An important
initial step in reducing the overall burden of CVD, as well as other ...
Cited by 16 - Related articles - All 13 versions

Management of the metabolic syndrome as a strategy for preventing the macrovascular …


CA Aguilar-Salinas, R Mehta, R Rojas, FJ … - Current Diabetes Reviews, 2005 - ingentaconnect.com
Carlos A. Aguilar-Salinas 1, *, Roopa Mehta 1 , Rosalba Rojas 2 , Francisco J.
Gómez-Pérez 1 , Gustavo ... Olaiz 2 and Juan A. Rull 1 ... 1 Departamento de
Endocrinología y Metabolismo del Instituto Nacional de Ciencias Médicas y ...
Cited by 12 - Related articles - BL Direct - All 4 versions

Visceral fat, waist circumference, and BMI: impact of race/ethnicity


JF Carroll, AL Chiapa, M Rodriquez, DR … - Obesity, 2008 - nature.com
* The costs of publication of this article were defrayed, in part, by the
payment of page charges. This article must, therefore, be hereby marked
"advertisement" in accordance with 18 USC Section 1734 solely to indicate ...
Cited by 12 - Related articles - All 3 versions

Assessing risk across the spectrum of patients with the metabolic syndrome


RS Rosenson - The American journal of cardiology, 2005 - Elsevier
The metabolic syndrome represents a constellation of interrelated risk factors
that identify individuals at increased risk for the development of type 2
diabetes mellitus and cardiovascular events. Currently, the major ...
Cited by 12 - Related articles - All 8 versions

Abdominal obesity, insulin resistance, and cardiovascular risk in pre-diabetes and type 2 …

- oxfordjournals.org
SM Haffner - European Heart Journal Supplements, 2006 - Eur Soc Cardiology
Cardiovascular (CV) disease remains the leading source of premature mortality in
western populations. There is an increasing prevalence of obesity, particularly
abdominal obesity. Nine states in the USA now report a prevalence of ...
Cited by 11 - Related articles - BL Direct - All 3 versions

Endothelial dysfunction and C-reactive protein are risk factors for diabetes in essential …

- diabetesjournals.org
F Perticone, R Maio, A Sciacqua, F Andreozzi, … - Diabetes, 2008 - Am Diabetes Assoc
RESEARCH DESIGN AND METHODS—We designed this study to determine whether
forearm endothelial dysfunction is an independent predictor of type 2 diabetes
in patients with essential hypertension. We enrolled 400 white ...
Cited by 12 - Related articles - BL Direct - All 3 versions

Do we need to target'prediabetic'hypertensive patients?


J Segura, C Campo, LM Ruilope, JL Rodicio - Journal of hypertension, 2005 - journals.lww.com
Patients at risk for diabetes development have been recently characterized as
those presenting higher baseline serum glucose concentration, increased body
mass index, elevated systolic blood pressure, reduced serum high-density ...
Cited by 9 - Related articles - BL Direct - All 6 versions

Differential effects of oral hypoglycemic agents on glucose control and cardiovascular risk


GI Uwaifo, RE Ratner - The American Journal of Cardiology, 2007 - Elsevier
Cardiovascular disease (CVD) burden remains the predominant cause of mortality
and morbidity in the United States and in most of the developed world. The
ongoing twin epidemics of obesity and type 2 diabetes mellitus provide a ...
Cited by 9 - Related articles - All 32 versions


Result Page: 

1

2

3

4

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google